from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1585c/-

LFCtreatmentdescriptionclass of inhibitor

-0.327

Amikacinug/mL Amikacintranslation

-0.786

Cap5-10ug/mL Capreomycintranslation

-0.685

Rox10-50 ug/mL Roxithromycintranslation

0.776

SM2-5 ug/mL Streptomycintranslation

-1.593

Tet5-10 ug/mL Tetracyclinetranslation

-1.486

Rif0.2-5ug/mL Rifampicintranscription

-0.541

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.164

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.225

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.046

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.477

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.217

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

4.629

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.671

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.028

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.258

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.275

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.135

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.341

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.972

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.809

KCN5-20 ug/mL Potassium cyaniderespiration

0.242

NaN30.2-2 mM Sodium aziderespiration

0.070

Nigericin50 uM Nigericinrespiration

0.301

TRC10-150 ug/mL Triclosanrespiration

0.879

TRZ10-25 ug/mL Thioridazinerespiration

1.962

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.415

menadione6-10 ug/mL Menadionerespiration

-0.652

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.448

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.434

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.067

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.098

NRP_1Non-replicating persistence stage 1dosRassociated

-0.220

Amp0.2mg/mL AmpicillincellWall

-0.386

Cephalexin20-100 ug/mL CephalexincellWall

-0.213

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.000

EMB10-20 ug/mL EthambutolcellWall

-0.118

Eta12-40 ug/mL EthionamidecellWall

-0.022

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.122

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.553

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.595

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.051

BZA0.12 mg/mL BenzamidearomaticAmides

0.060

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.540

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.235

H2O24 mM hydrogen peroxideDNAdamaging

-0.250

Levo10 ug/mL LevofloxacinDNAdamaging

-0.497

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.255

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.259

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.167

UVUV-irradiationDNAdamaging

2.931

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.577

Antimycin12.5-50 ug/mL Antimycin A?

-0.294

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.749

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.517

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.181

PA8240.2-2 ug/mL PA-824?

0.153

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.312

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.233

Verapamil50 uM Verapamil?

-0.211

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.124

methoxatin10-20 ug/mL Methoxatin?